Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
https://www.lse.co.uk/rns/NCYT/dhsc-dispute-update-mhmm29ok2b6ioho.html
I see NCYT being sued by gov in relation to their disputed contract, any risk here in terms of our dispute ?
The announcements this week although good, I am not getting carried away, these are only MOU's which are not legally binding and so until they announce a contract is signed with agreed terms I am keeping my powder dry
I doubt it, orientgene are who bought out Omegas Alva site, so looks like biosure are just distributing the orientgene test, if there was any manufacture, I am sure that Orientgene would use their own UK site
Of this is just sale of site, business and staff, does that also include transfer of the DAM contract and relationship with GAD/Mologic or is that deal also now dead?
keep reading the comments on the post , a number infer that they are just assembling components from elsewhere so they can say it is UK manufactured
I work in the LF industry and although the press released released by Orientgene has very poor English, it is fundamentally correct and Orietgene have registered a new company in Scotland called Accubio Limited - https://www.companieslist.co.uk/SC716479-accubio-limited, company was registered on December 12th of this year, so someway until it is up and running as there would significant transfer , validation and product registration required prior to any product being produced in Scotland.
Abingdon won't be making the biosure HIV test anymore, Biosure lost an arbitration with Chembio and have to immediately stop selling, pay over £2m and get all information back from their contract manufacturer (Abingdon)
Jrlomax , i was not talking about the covid test, Abingdon manufacture Biosure's Self Test HIV prodcut and it is this product that is at the centre of the Chembio action. My interpretation is that Biosure can no longer market this product and therefore Abingdon will have no further orders for this product. My question is what volume do we manufacture and what % of the contract manufacture revenue is associated with this product
Bullets from press release below
Instruct BioSure’s contract manufacturer to return certain materials to BioSure, including any Chembio confidential information and trade secrets within the manufacturer’s possession.
Return all files and records regarding the BioSure HIV Self Test to Chembio.
Stop using any results, conclusions, or data associated with any studies or performance evaluations related to the BioSure HIV Self Test.
Chembio Diagnostic Systems Prevails in International Arbitration Against BioSure (UK) Ltd
https://chembio.com/investors/press-releases/
As far as I am aware we manufacture this test for Biosure ( See quote from previous press release below), based on the above ruling, this could have reasonable impact as this states that the contract manufacturer must return all documentation and knowhow.
Below was a quote in Abingdon Press release around the deal with Biosure for their COvid-19 deal
Chris Yates, CEO of Abingdon Health, commented:
"We are delighted that BioSure have launched their product and equally happy to be their manufacturing partner. For individuals to be able to monitor their own antibody status at home is a great step in the management of COVID-19. Our own AbC-19 assay will complement this product and we expect the AbC-19 to gain additional utility in semi-quantitative format as recently announced. BioSure also distributes our AbC-19 test which is CE marked for professional use.
"This initiative allows us to build on our long-term collaboration with the BioSure team for whom we manufacture their HIV self-test in the same format as this new test. We are committed to supporting the deployment of these much-needed lateral flow tests to the UK and international markets. This is the first of several products we have previously noted to be going through the technical transfer process with others for COVID antigen and non-COVID applications to follow and which we expect to contribute to contract manufacturing revenue growth."
Just because the outside look the same does not mean it is the same test
Mologic test -developed and supplied by Mologic/Gad and licensed to Omega
Omega Diagnostics manufacture and supply Mologic test under Visitect brand
GAD contract manufacture Avacta test that uses same housing as Mologic test which is distributed by Medusa among others
All three companies will require separate HUA as they are different tests
Acon flow flex gas actually had eua from US unlike Innova https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.fda.gov/media/152700/download&ved=2ahUKEwik0q3Z4MHzAhXFolwKHWlNBhMQFnoECAwQAQ&usg=AOvVaw3pIMpcC7AnVwOr8pozhnAB
Just looked at your pictures, there is actually a faint test line there but only a partial line, if you repeated the test you main find you will have a faint positive line, this is potentially an invalid test due to the partial test line. the line is very faint so does seem to indicate a low result but i am not sure if the test is designed to pick up neutralising antibodies?
Wondfo test approved in 25th June, so.lelynit is that one going through self test approval that is being talked about with CIGA
Ciga is uk distributor for both Wondfo (one of china's largest lf companies with decent track record) and Hangzhou Alltest so could be either but both Chinese tests so unlikely a sovereign test......